Indication

Application

Contraindication

• with preparation and medication addiction; alcoholism;
• in patients with depression;
• with pathology of the respiratory system, which is accompanied by shortness of breath, obstructive syndrome;
• in patients with diabetes;
• with a decrease in blood pressure (pronounced);
• in case of acute myocardial infarction;
• with myasthenia;
• during pregnancy and breastfeeding;
• if the patient's age is ≤18 years (there are no data on use in the specified age group).

Side effects

• corvalol-Darnytsia is generally well tolerated.

• digestive system: constipation, a feeling of heaviness in the epigastric area.
• Long-term use of the preparation can cause liver dysfunction, episodes of nausea or vomiting;
• nervous system: dizziness (slightly pronounced), impaired coordination of movements, ataxia, nystagmus, weakness, fatigue, slowing down of the speed of reactions, hallucinations, headache, disorders of cognitive functions, confusion, drowsiness, paradoxical excitement, decreased concentration of attention;
• immune system: hypersensitivity reactions (including Quincke's edema);
• skin and mucous membranes: allergic reactions (including skin rash, itching, urticaria), as well as Lyell's and Stevens-Johnson syndromes (especially possible in the first weeks of treatment);
• blood system: anemia, thrombocytopenia, agranulocytosis;
• respiratory system: difficult breathing;
• cardiovascular system: decrease in heart rate, arterial hypotension;
• musculoskeletal system: the risk of bone tissue formation disorders (noted with long-term use of phenobarbital as part of medicines).

Special instructions

Interactions

Overdose

Storage conditions